Keele Research Repository

Article

Hawthorn, F, Bayliss, D, Wilson, TG, Bonfanti, A, Adibekyan, V, Alibert, Y, Sousa, SG, Collins, KA, Bryant, EM, Osborn, A, Armstrong, DJ, Abe, L, Acton, JS, Addison, BC, Agabi, K, Alonso, R, Alves, DR, Anglada-Escudé, G, Bárczy, T, Barclay, T, Barrado, D, Barros, SCC, Baumjohann, W, Bendjoya, P, Benz, W, Bieryla, A, Bonfils, X, Bouchy, F, Brandeker, A, Broeg, C, Brown, DJA, Burleigh, MR, Buttu, M, Cabrera, J, Caldwell, DA, Casewell, SL, Charbonneau, D, Charnoz, S, Cloutier, R, Cameron, AC, Collins, KI, Conti, DM, Crouzet, N, Czismadia, S, Davies, MB, Deleuil, M, Delgado-Mena, E, Delrez, L, Demangeon, ODS, Demory, B-O, Dransfield, G, Dumusque, X, Egger, JA, Ehrenreich, D, Eigmüller, P, Erickson, A, Essack, Z, Fortier, A, Fossati, L, Fridlund, M, Günther, MN, Güdel, M, Gandolfi, D, Gillard, H, Gillon, M, Gnilka, C, Goad, MR, Goeke, RF, Guillot, T, Hadjigeorghiou, A, Hellier, C, Henderson, BA, Heng, K, Hooton, MJ, Horne, K, Howell, SB, Hoyer, S, Irwin, JM, Jenkins, JS, Jenkins, JM, Jensen, ELN, Kane, SR, Kendall, A, Kielkopf, JF, Kiss, LL, Lacedelli, G, Laskar, J, Latham, DW, Etangs, ALD, Leleu, A, Lendl, M, Lillo-Box, J, Lovis, C, Mékarnia, D, Massey, B, Masters, T, Maxted, PFL ORCID: https://orcid.org/0000-0003-3794-1317, Nascimbeni, V, Nielsen, LD, O’Brien, SM, Olofsson, G, Osborn, HP, Pagano, I, Pallé, E, Persson, CM, Piotto, G, Plavchan, P, Pollacco, D, Queloz, D, Ragazzoni, R, Rauer, H, Ribas, I, Ricker, G, Ségransan, D, Salmon, S, Santerne, A, Santos, NC, Scandariato, G, Schmider, F-X, Schwarz, RP, Seager, S, Shporer, A, Simon, AE, Smith, AMS, Srdoc, G, Steller, M, Suarez, O, Szabó, GM, Teske, J, Thomas, N, Tilbrook, RH, Triaud, AHMJ, Udry, S, Van Grootel, V, Walton, N, Wang, SX, Wheatley, PJ, Winn, JN, Wittenmyer, RA and Zhang, H (2023) TOI-836: A super-Earth and mini-Neptune transiting a nearby K-dwarf. Monthly Notices of the Royal Astronomical Society, 520 (3). 3649 - 3668.

Schmid, P, Zaiss, M, Harper-Wynne, C, Ferreira, M, Dubey, S, Chan, S, Makris, A, Nemsadze, G, Brunt, AM, Kuemmel, S, Ruiz, I, Perelló, A, Kendall, A, Brown, J, Kristeleit, H, Conibear, J, Saura, C, Grenier, J, Máhr, K, Schenker, M, Sohn, J, Lee, KS, Shepherd, CJ, Oelmann, E, Sarker, S-J, Prendergast, A, Marosics, P, Moosa, A, Lawrence, C, Coetzee, C, Mousa, K and Cortés, J (2019) Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor–Positive Metastatic Breast Cancer. JAMA Oncology, 5 (11). 1556 - 1556.

Conference or Workshop Item

Schmid, P, Zaiss, M, Harper-Wynne, C, Ferreira, M, Dubey, S, Chan, S, Makris, A, Nemsadze, G, Brunt, AM, Kuemmel, S, Cabrero, IR, Perello, A, Kendall, A, Brown, J, Kristeleit, H, Conibear, J, Saura, C, Grenier, J, Mahr, K, Schenker, M, Sohn, JH, Lee, KS, Sarker, S-J, Coetzee, C, Mousa, K and Castan, JC (2018) MANTA - A randomized phase II study of fulvestrant in combination with the dual mTOR inhibitor AZD2014 or everolimus or fulvestrant alone in estrogen receptor-positive advanced or metastatic breast cancer. In: 2017 San Antonio Breast Cancer Symposium, December 5-9 2017, San Antonio, Texas.